BIO-key International Shares Drop Below 200-Day Average Amid Analyst Downgrades

BIO-key International Inc. (NASDAQ: BKYI) saw its share price fall below the 200-day moving average during trading on Thursday, marking a significant downturn for the company. The 200-day moving average was recorded at $0.72, while shares dipped as low as $0.6738 before closing at $0.72. The trading volume reached 3,958,363 shares, indicating heightened activity.

Several recent analyst reports have contributed to this decline. On January 21, 2023, Weiss Ratings reaffirmed a “sell (e+)” rating on BIO-key’s shares. Additionally, Wall Street Zen adjusted its rating to “sell” on January 3, 2023. Currently, one analyst has rated the stock as a sell, and according to MarketBeat, there is a consensus rating of “sell” for BIO-key International.

Institutional Investors Increase Holdings

In a notable shift, an institutional investor has raised its stake in BIO-key International. According to a recent disclosure to the Securities and Exchange Commission, Geode Capital Management LLC increased its holdings by 49.9% during the fourth quarter. The firm now owns 48,892 shares of the company after acquiring an additional 16,271 shares. As of the end of the last quarter, Geode Capital Management held approximately 0.45% of BIO-key International, valued at $26,000. Notably, institutional investors and hedge funds collectively own 26.51% of the company’s stock, indicating a significant interest from larger financial entities.

Company Overview

BIO-key International specializes in fingerprint biometric identity and access management solutions, catering to both enterprise and government clients. The company’s portfolio includes a variety of fingerprint readers and authentication software aimed at verifying user identities across both physical and digital domains. By employing proprietary template-on-card and template-on-device technologies, BIO-key enhances security and facilitates user access without the need for traditional passwords. Alongside hardware sensors, the firm provides software platforms that integrate seamlessly with existing IT infrastructures, including Microsoft Active Directory and major workforce management systems.

As the market watches closely, the future performance of BIO-key International will depend on both analyst sentiment and institutional investment trends. Continued monitoring of these dynamics will be essential for stakeholders.